The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Verification of the fetal valproate syndrome phenotype
Open accessAbstract
We have evaluated 19 children who were exposed to valproic acid (VPA) in utero to look for manifestations of a fetal valproate syndrome (FVS), as proposed by Di Liberti et al. [1984]. We found no consistent alterations of pre‐ or postnatal growth with exposure to VPA monotherapy. Postnatal growth deficiency and microcephaly were present however, in two thirds of children exposed to VPA in combination with other anticonvulsants. Developmental delay or neurologic abnormality was found in 71% of those exposed to VPA monotherapy, and in 90% of those exposed to VPA and other anticonvulsants. Craniofacial anomalies, which can be seen with other anticonvulsant exposures, including midface hypoplasia, short nose with a broad and / or flat bridge, epicanthal folds, minor abnormalities of the ear, philtrum or lip, and micrognathia were also found in infants whose mothers used VPA. Prominent metopic ridge and outer orbital ridge deficiency or bifrontal narrowing and certain major anomalies such as tracheomalacia, talipes equinovarus (with intact spine) and lumbosacral meningomyelocele seem to be peculiar to infants with VPA exposure. Other defects such as urogenital anomalies, inguinal or umbilical hernias, and minor digital anomalies that are common to other prenatal anticonvulsant exposures are also occasionally found in those exposed to VPA. Heart defects have been found in infants exposed to nearly every class of anticonvulsant although the types of defects associated with maternal VPA use may be clarified when classified by pathogenetic mechanism. Our findings overall are in agreement with the report of Di Liberti et al. [1984].
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MATERNAL VALPROIC ACID AND CONGENITAL NEURAL TUBE DEFECTS
Robert, E., & Guibaud, P. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90908-4 · Cited by 539
Chemically induced birth defects
(1986) · Comparative Biochemistry and Physiology Part A: Physiology · doi:10.1016/0300-9629(86)90073-3 · Cited by 491
Normal and abnormal development of the human nervous system
Lemire, R. J., & etc. (1975) · Medical Entomology and Zoology · Cited by 421
Normal and abnormal development of the human nervous system
Shelburne, S. A. (1976) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(76)90112-7 · Cited by 408
DiLiberti, J. H., Farndon, P. A., Dennis, N. R., & Curry, C. J. R. (1984) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320190308 · Cited by 399
IN-UTERO EXPOSURE TO VALPROATE AND NEURAL TUBE DEFECTS
Lindhout, D., & Schmidt, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91711-3 · Cited by 299
Wt, W. (1984) · PubMed · Cited by 291
Jäger-Roman, E., Deichl, A., Jakob, S., Hartmann, A.-M., Koch, S., Rating, D., Steldinger, R., Nau, H., & Helge, H. (1986) · The Journal of Pediatrics · doi:10.1016/s0022-3476(86)80949-0 · Cited by 282
VALPROIC ACID AND SPINA BIFIDA
Bjerkedal, T., Czeizel, A., Goujard, J., Kallen, B., Mastroiacova, P., Nevin, N., Oakley, G., & Robert, E. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90018-6 · Cited by 265
Nau, H., Rating, D., Koch, S., Häuser, I., & Helge, H. (1981) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32875-2 · Cited by 230
Cited by
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
Drugs in Pregnancy and Lactation
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-11-902_3 · Cited by 1,075
Behavioral Alterations in Rats Prenatally Exposed to Valproic Acid: Animal Model of Autism
Schneider, T., & Przewłocki, R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300518 · Cited by 959
A clinical study of 57 children with fetal anticonvulsant syndromes
Moore, S. J., Turnpenny, P., Quinn, A., Glover, S., Lloyd, D. J., Montgomery, T., & Dean, J. C. S. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.7.489 · Cited by 562
Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy, A. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.02.014 · Cited by 526
Fetal valproate syndrome and autism: additional evidence of an association
Williams, G., King, J., Cunningham, M., Stephan, M., Kerr, B., & Hersh, J. H. (2001) · Developmental Medicine and Child Neurology · doi:10.1017/s001216220100038x · Cited by 422
The intense world syndrome-an alternative hypothesis for autism
Markram, H. (2007) · Frontiers in Neuroscience · doi:10.3389/neuro.01.1.1.006.2007 · Cited by 394
Increased rate of major malformations in offspring exposed to valproate during pregnancy
Wyszynski, D. F., Nambisan, M., Surve, T., Alsdorf, R. M., Smith, C. R., & Holmes, L. B. (2005) · Neurology · doi:10.1212/01.wnl.0000154516.43630.c5 · Cited by 390
The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs
Bromley, R. L., Mawer, G. E., Briggs, M., Cheyne, C., Clayton-Smith, J., Garcia-Finana, M., Kneen, R., Lucas, S. B., Shallcross, R., Baker, G. A., et al. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304270 · Cited by 367
Arndt, T. L., Stodgell, C. J., & Rodier, P. M. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.11.001 · Cited by 360
Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child
Weston, J., Bromley, R., Jackson, C. F., Adab, N., Clayton-Smith, J., Greenhalgh, J., Hounsome, J., McKay, A. J., Tudur Smith, C., & Marson, A. G. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010224.pub2 · Cited by 347
Fetal Valproate Syndrome: Clinical and Neuro‐developmental Features in Two Sibling Pairs
Christianson, A. L., Chester, N., & Kromberg, J. G. R. (1994) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1994.tb11858.x · Cited by 336
Nau, H., Hauck, R., & Ehlers, K. (1991) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1991.tb01303.x · Cited by 297
Selderslaghs, I. W. T., Van Rompay, A. R., De Coen, W., & Witters, H. E. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.05.004 · Cited by 292
Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child
Bromley, R., Weston, J., Adab, N., Greenhalgh, J., Sanniti, A., McKay, A. J., Tudur Smith, C., & Marson, A. G. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010236.pub2 · Cited by 277
A New Neurobehavioral Model of Autism in Mice: Pre- and Postnatal Exposure to Sodium Valproate
Wagner, G. C., Reuhl, K. R., Cheh, M., McRae, P., & Halladay, A. K. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0117-y · Cited by 277
IQ at 6 years after in utero exposure to antiepileptic drugs: A controlled cohort study
Baker, G. A., Bromley, R. L., Briggs, M., Cheyne, C. P., Cohen, M. J., García-Fiñana, M., Gummery, A., Kneen, R., Loring, D. W., Mawer, G., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001182 · Cited by 268
CARTER, J. D., LADHANI, A., RICCA, L. R., VALERIANO, J., & VASEY, F. B. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.080545 · Cited by 256
ACOG Committee on Clinical Practice Guidelines–Obstetrics (2023) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000005202 · Cited by 252
Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth
Dean, J. C. S., Hailey, H., Moore, S. J., Lloyd, D. J., Turnpenny, P. D., & Little, J. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.4.251 · Cited by 252
Craniosynostosis and fetal exposure to sodium valproate
Lajeunie, E., Barcik, U., Thorne, J. A., Ghouzzi, V. E., Bourgeois, M., & Renier, D. (2001) · Journal of Neurosurgery · doi:10.3171/jns.2001.95.5.0778 · Cited by 109
Creeley, C. E., & Denton, L. K. (2019) · Brain Sciences · doi:10.3390/brainsci9090235 · Cited by 78
The incidence of craniosynostosis in the Netherlands, 1997–2007
Kweldam, C. F., van der Vlugt, J. J., & van der Meulen, J. J. N. M. (2011) · Journal of Plastic, Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2010.08.026 · Cited by 77
Edalatmanesh, M. A., Nikfarjam, H., Vafaee, F., & Moghadas, M. (2013) · Brain Research · doi:10.1016/j.brainres.2013.06.024 · Cited by 76
Craniosynostosis and nutrient intake during pregnancy
Carmichael, S. L., Rasmussen, S. A., Lammer, E. J., Ma, C., Shaw, G. M., & Study, A. T. N. B. D. P. (2010) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20717 · Cited by 42
“Studies have also suggested that use of valproic acid, a folate antagonist, is associated with metopic synostosis (Ardinger et al., 1988; Lajeunie et al., 1998).”
Self-citationEndocrine disrupting effects on morphological synaptic plasticity
Zsarnovszky, A., Alymbaeva, D., Jocsak, G., Szabo, C., Mária Schilling-Tóth, B., & Sandor Kiss, D. (2024) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2024.101157 · Cited by 7
“Epidemiological studies in humans have reported an increased risk of autism and so called “ fetal valproate syndrome ” , following prenatal VPA exposure, though not consistently across all investigations (DiLiberti et al., 1984; Ardinger et al., 1988; Eadie and Vajda, 2005; Koren et al., 2006).”
Metadata
- Authors
- Ardinger, H. H., Atkin, J. F., Blackston, R. D., Elsas, L. J., Clarren, S. K., Livingstone, S., Flannery, D. B., Pellock, J. M., Harrod, M. J., Lammer, E. J., Majewski, F., Schinzel, A., Toriello, H. V., Hanson, J. W., Optiz, J. M., & Reynolds, J. F.
- Venue
- American Journal of Medical Genetics
- Publisher
- Wiley
- Published
- 1988-01
- Volume
- 29
- Issue
- 1
- Pages
- 171-185
- ISSN
- 0148-7299 (ISSN-L)
- 1096-8628
- OpenAlex
- W1999366195
- Cited by
- 302
- References
- 28
- FWCI
- 13.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.